癌・感染症の遺伝子診断(1)
司会のことば
渡 辺 伸一郎*1 網 野 信 行*2
Genetic Diagnosis of Cancer and Infection
−Chairmen's Introductory Remarks
Shin-ichiro WATANABE, MD*1 and Nobuyuki AMINO, MD*2
Expectations are growing for medical care in the post-genome era. It is no exaggeration to say that the functions of reportedly 30,000 to 40,000 genes and their relationships with diseases have only recently began to be elucidated.
It is interesting how advances in human genetic research are being applied
to the field of clinical laboratory science. This symposium addressed the
topics of the diagnosis of benign and malignant thyroid tumors, malignancy
grading and prognosis prediction in digestive tract cancers, relationships
between genetic polymorphisms of drug-metabolizing enzymes and effects
and side-effects of anticancer drugs, methods of detecting and identifying
pathogenic microorganisms, and genes for the pathogenicity and drug-resistance
of microorganisms.
[Rinsho Byori 51 : 150〜151, 2003]
*1Department of Clinical Laboratory Medicine, Tokyo Women's Medical University, Shinjuku-ku, Tokyo 162-8666
*1東京女子医科大学中央検査部(〒162-8666 東京都新宿区河田町8-1)
*2大阪大学大学院医学系研究科(〒565-0871 吹田市山田丘2-2)
E-mail :watanabe@clabo.zengaku.twmu.ac.jp